2 news items
UNITY Biotechnology, Inc. Reports First Quarter 2024 Financial Results and Business Updates
UBX
14 May 24
actual results, levels of activity, performance, or achievements to be materially different from the information expressed or implied by these forward
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
UBX
23 Apr 24
, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from
- Prev
- 1
- Next